NSPR insider transaction filings
InspireMD, Inc. — 36 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-29. Screen NSPR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | Stuka Paul — Director | Purchase (P): 20,000 @ $0.88 | EDGAR |
| 2026-05-21 | 4 | Gleason Shane Thomas — Chief Commercial Officer | Sale (S): 3,858 @ $2.71 · Sale (S): 2,476 @ $2.61 · Sale (S): 3,660 @ $2.46 · Sale (S): 2,454 @ $2.51 · Sale (S): 9,923 @ $2.55 · Sale (S): 7,073 @ $2.51 · +8 more | EDGAR |
| 2026-05-15 | 4 | Stuka Paul — Director | Purchase (P): 10,000 @ $1.16 · Purchase (P): 5,000 @ $1.15 | EDGAR |
| 2026-05-13 | 4 | Slosman Marvin — CEO and President, Director | Purchase (P): 21,000 @ $1.20 | EDGAR |
| 2026-05-13 | 4/A | Stuka Paul — Director | Purchase (P): 65,626 @ $1.16 · Purchase (P): 10,000 @ $1.19 | EDGAR |
| 2026-05-12 | 4 | Stuka Paul — Director | Purchase (P): 65,626 @ $1.16 · Purchase (P): 10,000 @ $1.19 | EDGAR |
| 2026-05-08 | 4 | Stuka Paul — Director | Purchase (P): 1,517 @ $1.12 · Purchase (P): 6,378 @ $1.15 | EDGAR |
| 2026-05-08 | 4 | Ward Scott R. — Director | Purchase (P): 15,995 @ $1.15 · Purchase (P): 73,255 @ $1.15 | EDGAR |
| 2026-05-08 | 4 | ROUBIN GARY S — Director | Purchase (P): 90,000 @ $1.18 | EDGAR |
| 2026-02-23 | 4/A | Stuka Paul — Director | Purchase (P): 2,710 @ $1.81 | EDGAR |
| 2026-02-02 | 4 | Gleason Shane Thomas — Chief Commercial Officer | Sale (S): 2,909 @ $1.58 · Sale (S): 2,250 @ $1.61 · Sale (S): 2,955 @ $1.59 · Sale (S): 17,593 @ $1.62 · Sale (S): 8,411 @ $1.57 · Sale (S): 4,781 @ $1.66 · +4 more | EDGAR |
| 2026-01-16 | 4 | Tommasoli Andrea — Chief Operating Officer | Grant/award (A): 226,695 @ $0 | EDGAR |
| 2026-01-16 | 4 | Stuka Paul — Director | Grant/award (A): 132,076 @ $0 | EDGAR |
| 2026-01-16 | 4 | Slosman Marvin — CEO and President, Director | Grant/award (A): 1,114,792 @ $0 | EDGAR |
| 2026-01-16 | 4 | Lawless Michael A — Chief Financial Officer | Grant/award (A): 226,695 @ $0 | EDGAR |
| 2026-01-16 | 4 | Gleason Shane Thomas — Chief Commercial Officer | Grant/award (A): 453,390 @ $0 | EDGAR |
| 2026-01-16 | 4 | Dearen Danny L. — Director | Grant/award (A): 44,030 @ $0 | EDGAR |
| 2026-01-16 | 4 | COHEN RAYMOND W — Director | Grant/award (A): 44,030 @ $0 | EDGAR |
| 2026-01-16 | 4 | BERMAN MICHAEL — Director | Grant/award (A): 88,053 @ $0 | EDGAR |
| 2026-01-16 | 4 | Ward Scott R. — Director | Grant/award (A): 88,053 @ $0 | EDGAR |
| 2026-01-16 | 4 | ROUBIN GARY S — Director | Grant/award (A): 88,053 @ $0 | EDGAR |
| 2025-12-31 | 4 | Arnold Kathryn — Director | Grant/award (A): 55,556 @ $0 · Grant/award (A): 26,276 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Stuka Paul — Director | Purchase (P): 5,073 @ $1.81 | EDGAR |
| 2025-12-08 | 4 | Stuka Paul — Director | Purchase (P): 5,073 @ $1.86 | EDGAR |
| 2025-12-05 | 4 | Stuka Paul — Director | Purchase (P): 10,130 @ $1.85 | EDGAR |
| 2025-11-13 | 4 | Stuka Paul — Director | Purchase (P): 13,431 @ $1.62 | EDGAR |
| 2025-10-09 | 4 | ROUBIN GARY S — Director | Grant/award (A): 48,000 @ $0 | EDGAR |
| 2025-09-17 | 4 | Kester Thomas J — Director | Grant/award (A): 37,815 @ $0 · Grant/award (A): 19,041 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | Slosman Marvin — CEO and President, Director | Purchase (P): 10,330 @ $2.42 | EDGAR |
| 2025-08-01 | 4 | Stuka Paul — Director | Purchase (P): 20,661 @ $2.42 | EDGAR |
| 2025-08-01 | 4 | Kester Thomas J — Director | Purchase (P): 30,991 @ $2.42 | EDGAR |
| 2025-08-01 | 4 | ROUBIN GARY S — Director | Purchase (P): 41,322 @ $2.42 | EDGAR |
| 2025-07-23 | 4 | Stuka Paul — Director | Option exercise/expiry (X): 87,500 @ $1.38 · Option exercise/expiry (X): 87,500 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | Kester Thomas J — Director | Option exercise/expiry (X): 30,624 @ $1.38 · Option exercise/expiry (X): 30,624 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | BERMAN MICHAEL — Director | Option exercise/expiry (X): 61,248 @ $1.38 · Option exercise/expiry (X): 61,248 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | ROUBIN GARY S — Director | Option exercise/expiry (X): 30,624 @ $1.38 · Option exercise/expiry (X): 30,624 (derivative) @ $0 | EDGAR |
Recent 8-K events — InspireMD, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NSPR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →